Literature DB >> 22306945

Abnormal immune regulation and low-grade inflammation in IBS: does one size fit all?

Max Schmulson1, William D Chey.   

Abstract

Evidences suggest that there is low-grade inflammation in the colonic mucosa and/or a state of immune activation in patients with irritable bowel syndrome (IBS). Results from available studies are inconsistent mainly because of differences in measures, methodologies and study populations. In this issue, Chang et al. evaluated a comprehensive set of cytokines, immune markers and immune-related cells in patients with non post infectious IBS (non PI-IBS) and controls. The main finding was a lower expression of the mRNA of the anti-inflammatory IL-10 cytokine in the colonic mucosa of women with non PI-IBS without any differences in the cell counts. These results suggest that in non PI-IBS, there is altered immune regulation/activation without evidence of low-grade mucosal inflammation. Further, PI and non PI-IBS may be associated with different alterations in immune function/activation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22306945     DOI: 10.1038/ajg.2011.427

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  9 in total

1.  Increased risk of osteoporosis-related fractures in patients with irritable bowel syndrome.

Authors:  D J Stobaugh; P Deepak; E D Ehrenpreis
Journal:  Osteoporos Int       Date:  2012-09-20       Impact factor: 4.507

Review 2.  Impact of psychological stress on irritable bowel syndrome.

Authors:  Hong-Yan Qin; Chung-Wah Cheng; Xu-Dong Tang; Zhao-Xiang Bian
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

3.  Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine.

Authors:  Kara Gross Margolis; Korey Stevanovic; Zhishan Li; Qi Melissa Yang; Tamas Oravecz; Brian Zambrowicz; Kanchan G Jhaver; Alexander Diacou; Michael D Gershon
Journal:  Gut       Date:  2013-06-07       Impact factor: 23.059

Review 4.  Recent developments in the pathophysiology of irritable bowel syndrome.

Authors:  Magdy El-Salhy
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

5.  What role does wheat play in the symptoms of irritable bowel syndrome?

Authors:  Shanti Eswaran; Akash Goel; William D Chey
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-02

Review 6.  The malabsorption of commonly occurring mono and disaccharides: levels of investigation and differential diagnoses.

Authors:  Martin Raithel; Michael Weidenhiller; Alexander Fritz-Karl Hagel; Urban Hetterich; Markus Friedrich Neurath; Peter Christopher Konturek
Journal:  Dtsch Arztebl Int       Date:  2013-11-15       Impact factor: 5.594

7.  Increased Vδ1γδT cells predominantly contributed to IL-17 production in the development of adult human post-infectious irritable bowel syndrome.

Authors:  L W Dong; X N Sun; Z C Ma; J Fu; F J Liu; B L Huang; D C Liang; D M Sun; Cheng Lan
Journal:  BMC Gastroenterol       Date:  2021-06-30       Impact factor: 3.067

8.  Improved Symptom Profiles and Minimal Inflammation in IBS-D Patients Undergoing a Long-Term Low-FODMAP Diet: A Lipidomic Perspective.

Authors:  Antonella Orlando; Valeria Tutino; Maria Notarnicola; Giuseppe Riezzo; Michele Linsalata; Caterina Clemente; Laura Prospero; Manuela Martulli; Benedetta D'Attoma; Valentina De Nunzio; Francesco Russo
Journal:  Nutrients       Date:  2020-06-02       Impact factor: 5.717

Review 9.  Pathogenesis, Experimental Models and Contemporary Pharmacotherapy of Irritable Bowel Syndrome: Story About the Brain-Gut Axis.

Authors:  S W Tsang; K K W Auyeung; Z X Bian; J K S Ko
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.